Skip to Main Content

Author Details

Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
2003
292
54
PMIDPaper TitleJournal TitlePublished Year
36151773A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.Cancer Med2023
37557966The relationship of lifetime history of depression on the ovarian tumor immune microenvironment.Brain Behav Immun2023
37525619Associations between prediagnostic aspirin use and ovarian tumor gene expression.Cancer Med2023
37407670A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.Sci Data2023
36940177Measurement of Ovarian Tumor Immune Profiles by Multiplex Immunohistochemistry: Implications for Epidemiologic Studies.Cancer Epidemiol Biomarkers Prev2023
36761962Predictors of residual disease after debulking surgery in advanced stage ovarian cancer.Front Oncol2023
36929081Statistics and Machine Learning in Mass Spectrometry-Based Metabolomics Analysis.Methods Mol Biol2023
36929076A Primer on Preprocessing, Visualization, Clustering, and Phenotyping of Barcode-Based Spatial Transcriptomics Data.Methods Mol Biol2023
36929074Statistical Methods for Integrative Clustering of Multi-omics Data.Methods Mol Biol2023
36929070Multi-omics Data Deconvolution and Integration: New Methods, Insights, and Translational Implications.Methods Mol Biol2023
36861411<i>PARP1</i> and <i>POLD2</i> as prognostic biomarkers for multiple myeloma in autologous stem cell transplant.Haematologica2023
36094443Pilot Study in Investigating Material Financial Toxicity Markers by Age in Cancer Patients.J Adolesc Young Adult Oncol2023
36318652Lifetime Exposure to Cigarette Smoke and Risk of Ovarian Cancer by T-cell Tumor Immune Infiltration.Cancer Epidemiol Biomarkers Prev2023
33983850Clinical Trial Availability by Location for 1000 Simulated AYA Patients.J Adolesc Young Adult Oncol2022
35653140Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.Clin Cancer Res2022
35562768Lifetime ovulatory years and ovarian cancer gene expression profiles.J Ovarian Res2022
36018828Prognostic features of endometrial cancer metastasis to the central nervous system.PLoS One2022
35319481A Question-and-Answer System to Extract Data From Free-Text Oncological Pathology Reports (CancerBERT Network): Development Study.J Med Internet Res2022
35094053Prospective Analyses of Sedentary Behavior in Relation to Risk of Ovarian Cancer.Am J Epidemiol2022
35244678Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2022
35032707Mitochondrial DNA sequence variation and risk of glioma.Mitochondrion2022
35235563Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.PLoS Comput Biol2022
35234924Summarizing internal dynamics boosts differential analysis and functional interpretation of super enhancers.Nucleic Acids Res2022
35258565spatialGE: quantification and visualization of the tumor microenvironment heterogeneity using spatial transcriptomics.Bioinformatics2022
32926366Statistical and Bioinformatics Analysis of Data from Bulk and Single-Cell RNA Sequencing Experiments.Methods Mol Biol2021
33613870Wide and deep learning for automatic cell type identification.Comput Struct Biotechnol J2021
33890980Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes.Blood Adv2021
34734969spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data.Bioinformatics2021
34669147Mitochondrial DNA sequence variation and risk of meningioma.J Neurooncol2021
33989014Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.JCO Clin Cancer Inform2021
34204319Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.Cancers (Basel)2021
33452133The harsh microenvironment in early breast cancer selects for a Warburg phenotype.Proc Natl Acad Sci U S A2021
32975643"I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.Support Care Cancer2021
32859560The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.J Geriatr Oncol2021
32851660Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.Int J Cancer2021
31199438GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysis.Bioinformatics2020
31999549Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.Comput Biol Med2020
31839342Predictors of survival trajectories among women with epithelial ovarian cancer.Gynecol Oncol2020
31780380Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.Clin Breast Cancer2020
33117761Ontogeny Related Changes in the Pediatric Liver Metabolome.Front Pediatr2020
33396385DNA Methylation in Ovarian Cancer Susceptibility.Cancers (Basel)2020
32696098Utility of Taking Additional Margins When Performing Breast-Conserving Surgery with Intraoperative Radiation Therapy for Early Breast Cancer.World J Surg2020
32386107Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.Pediatr Blood Cancer2020
32176331An evolutionary framework for treating pediatric sarcomas.Cancer2020
31437624Statistical genomics in rare cancer.Semin Cancer Biol2020
31549389Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.Clin Pharmacol Ther2020
31600840Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center.Clin Genet2020
30548250Lenalidomide-based response-adapted therapy for older adults without high risk myeloma.Br J Haematol2019
30026572Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.Leukemia2019
31550266Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines.PLoS One2019
  • 1 - 50 of 292

Recommended Authors

the University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 6
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Brigham Young University
Career Start Year 2008
Number of shared co-authors 2
Chungnam National University
Career Start Year 2007
Number of shared co-authors 2
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year 2006
Number of shared co-authors 4
Duke University
Career Start Year 2005
Number of shared co-authors 40
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
University of Dhaka
Career Start Year 2004
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 10
University of California
Career Start Year 2003
Number of shared co-authors 1
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 25
Queen's University
Career Start Year 2002
Number of shared co-authors 9
National Institute of Environmental Health Sciences
Career Start Year 2002
Number of shared co-authors 18
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 12
University of California los angeles
Career Start Year 2001
Number of shared co-authors 5
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 8
Keck School of Medicine, University of Southern California
Career Start Year 2001
Number of shared co-authors 96
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 8
University of Pittsburgh School of Public Health
Career Start Year 2001
Number of shared co-authors 1
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 54
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 26
Yale University
Career Start Year 1995
Number of shared co-authors 19
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 6
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 7
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 19
University of California los angeles
Career Start Year 1970
Number of shared co-authors 40

Collaborators

Mayo Clinic College of Medicine
Co-authored papers 143
Rollins School of Public Health, Emory University
Co-authored papers 85
Cedars-Sinai Medical Center
Co-authored papers 76
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 76
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 73
Duke School of Medicine
Co-authored papers 67
University of Cambridge
Co-authored papers 64
UCL EGA Institute for Women's Health, University College London
Co-authored papers 64
German Cancer Research Center (DKFZ)
Co-authored papers 63
College of Nursing, University of South Florida
Co-authored papers 63
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 59
Huntsman Cancer Institute, University of Utah
Co-authored papers 59
Co-authored papers 57
Fred Hutchinson Cancer Research Center
Co-authored papers 56
University of Michigan School of Public Health ann arbor
Co-authored papers 56
University of Southern California
Co-authored papers 56
Otto-Friedrich-University Bamberg
Co-authored papers 56
National Cancer Institute, National Institutes of Health
Co-authored papers 56
Co-authored papers 55
Co-authored papers 54
University of California irvine
Co-authored papers 53
QIMR Berghofer Medical Research Institute
Co-authored papers 53
Co-authored papers 49
Memorial Sloan-Kettering Cancer Center
Co-authored papers 46
David Geffen School of Medicine, University of California los angeles
Co-authored papers 46
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 45
Co-authored papers 45
Mayo Clinic
Co-authored papers 43
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 42
National Cancer Institute
Co-authored papers 41